This review explores the role of TyG-BMI in diabetes management and cardiovascular disease, highlighting clinical practices and future directions.
This article focuses on the Triglyceride-Glucose Body Mass Index (TyG-BMI) in diabetes and its associated cardiovascular complications. It elaborates on the basic concepts, current clinical practices, technological advancements, controversies, challenges, and future directions related to TyG-BMI. By integrating the findings from numerous studies, we aimed to provide a comprehensive understanding of the role of TyG-BMI in diabetes and cardiovascular disease research, diagnosis, and treatment, highlighting its significance and potential for improving the management of diabetic cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: